Skip to main content
The Markets by Proactive
Go to Proactive Australia

Pharma & Biotech

BWX signs US$80M deal to acquire U.S. skin care player

The company will fund the transaction via a A$100 million entitlement offer.

BWX Ltd (ASX:BWX) has entered into a binding agreement to acquire Andalou Naturals, a U.S. skin, hair and body care brand for an initial consideration of US$80 million.

Importantly, Andalou is the number one selling facial skin care brand in the U.S. natural channel.

The acquisition of Andalou is highly complementary to Melbourne based BWX’s existing portfolio of skin, hair and body care products.

The combination of three leading brands, Sukin, Mineral Fusion and Andalou Naturals, provides a great platform on which to further develop BWX’s sales and distribution.

In particular, the acquisition creates a quality U.S. distribution network, adding key retailers such as Target, CVS, Kroger and Walgreens and will support the entry of other BWX brands into the U.S.

Andalou is expected to generate a revenue of US$41 million for FY2018 and a pro forma EBITDA of US$ 8.5 million.

The acquisition will facilitate cost savings by shifting the production of several high-volume Andalou products to BWX’s purpose built facility in Dandenong, Victoria.

BWX estimates US$1 million of annualised cost synergies by the end of the first full year of ownership.

Significantly, the transaction is expected to be 10% EPS accretive on a pro forma FY2018 basis before expected annual cost synergies.

The initial consideration will be comprised of US$64 million in cash and US$16 million in BWX shares.

BWX will fund the cash consideration via a fully underwritten 1 for 5.7 pro-rata accelerated renounceable entitlement offer to raise A$100 million.

In addition to the initial consideration, there are potential additional amounts payable up to US$11.2 million over the next 5 years, subject to Andalou achieving particular financial milestones.